Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MediNordic Aesthetics ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   6.2% 3.8% 2.7% 2.2% 1.9% 1.4% 9.8% 9.6%   Credit score (0-100)   39 52 59 65 70 77 25 26   Credit rating   BBB BBB BBB BBB A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.1 1.5 28.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   718 473 606 1,818 3,851 2,718 0.0 0.0   EBITDA   534 123 193 554 2,120 735 0.0 0.0   EBIT   493 82.4 152 514 2,079 720 0.0 0.0   Pre-tax profit (PTP)   461.8 35.0 117.7 528.5 2,062.3 621.3 0.0 0.0   Net earnings   353.2 25.1 90.5 405.7 1,598.1 473.3 0.0 0.0   Pre-tax profit without non-rec. items   462 35.0 118 528 2,062 621 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   179 138 97.4 56.6 15.8 0.0 0.0 0.0   Shareholders equity total   405 430 520 926 2,524 2,147 2,097 2,097   Interest-bearing liabilities   51.1 42.5 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   973 889 1,153 2,252 3,868 3,099 2,097 2,097   Net Debt   51.1 42.5 -403 -345 -651 -955 -2,097 -2,097     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   718 473 606 1,818 3,851 2,718 0.0 0.0   Gross profit growth   5,377.7% -34.1% 28.0% 200.1% 111.8% -29.4% -100.0% 0.0%   Employees   1 1 0 0 0 2 0 0   Employee growth %   0.0% 0.0% -100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   973 889 1,153 2,252 3,868 3,099 2,097 2,097   Balance sheet change%   46.7% -8.6% 29.6% 95.3% 71.8% -19.9% -32.3% 0.0%   Added value   533.6 123.1 193.1 554.4 2,120.1 735.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -82 -82 -82 -82 -82 -32 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   68.7% 17.4% 25.2% 28.3% 54.0% 26.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   60.3% 8.9% 14.9% 31.4% 68.0% 20.7% 0.0% 0.0%   ROI %   192.2% 17.5% 30.3% 73.9% 120.5% 30.8% 0.0% 0.0%   ROE %   154.9% 6.0% 19.0% 56.1% 92.7% 20.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   41.6% 48.3% 45.1% 41.1% 65.3% 69.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   9.6% 34.5% -208.8% -62.3% -30.7% -129.8% 0.0% 0.0%   Gearing %   12.6% 9.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   121.6% 101.8% 164.2% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.0 0.7 1.0 1.1 2.5 2.6 0.0 0.0   Current Ratio   1.4 1.6 1.6 1.6 2.8 3.2 0.0 0.0   Cash and cash equivalent   0.0 0.0 403.2 345.5 651.3 954.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   212.5 286.5 395.8 840.6 2,479.5 2,118.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   534 123 0 0 0 368 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   534 123 0 0 0 368 0 0   EBIT / employee   493 82 0 0 0 360 0 0   Net earnings / employee   353 25 0 0 0 237 0 0